Showing all 5 results
Alluvi Glow GHK-Cu 70mg — tri-peptide research kit combining GHK-Cu (50mg), BPC-157 (10mg), and TB-500 (10mg). Two pre-filled pens per kit. 99.4% purity, Janoshik Analytical tested. Cold-chain UK delivery. For laboratory and scientific research use only.
Alluvi Retatrutide 20mg – research-grade triple-agonist peptide (GLP-1, GIP, Glucagon). 20mg total active compound supplied as 4 doses of 5mg. Target pathways: GLP-1, GIP, and Glucagon receptors. Store at 2°C to 8°C. For laboratory and scientific research use only.
Alluvi Retatrutide 40mg – research-grade triple-agonist peptide (GLP-1, GIP, Glucagon). 40mg total active compound supplied as 4 doses of 10mg. Target pathways: GLP-1, GIP, and Glucagon receptors. Store at 2°C to 8°C. For laboratory and scientific research use only.
Alluvi Tirzepatide (Mounjaro) 40mg — dual-agonist research peptide targeting GLP-1 and GIP receptors. 40mg total active compound supplied as 4 doses of 10mg. 99.85% purity, Janoshik Analytical tested, batch COA available. Cold-chain UK delivery. For laboratory and scientific research use only.
Alluvi Wolverine Stack — dual-peptide research pen combining BPC-157 (20mg) and TB-500 (20mg). 40mg total, 4 pre-calibrated doses of 10mg. 99.5% purity, Janoshik Analytical tested (batch BP1701FSR). Cold-chain UK delivery. For laboratory and scientific research use only.
No products in the basket.
